ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZurichcellvie AG
cellvie AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of cellvie is the development of cell-based medicines, in particular by exploiting the therapeutic potential of mitochondria. The company focuses on the development of Therapeutic Mitochondrial Transplantation (TMT), a novel treatment approach aimed at improving cellular energy production and thereby treating various diseases and conditions such as ischemia-reperfusion injury, aging and others.

AI-generated
Offering

Products & services

Industry:
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

cellvie AG

Research & Development
Pharmaceutical Industry
✓ Offered3
Therapeutic mitochondria transplantation
Therapeutic mitochondria transplantation for augmentation and replacement of mitochondria, to revitalize cellular energy metabolism and treat damaged cells directly.
Treatment of ischemia-reperfusion injuries
Treatment of ischemia-reperfusion injuries, initially in kidney transplantations; with a focus on organ salvage, less delayed graft function, and later expansion to other indications.
Mitochondria-assisted gene therapy for genetic disorders
Topical mitochondria-assisted gene therapy for targeted gene delivery, initially in Epidermolysis bullosa; with restoration of Type VII collagen and expansion to other indications.
Trust & reputation

ranQ Trust Score of cellvie AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

cellvie AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
cellvie AG scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
cellvie AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
cellvie AG scores 46.5 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.82.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

cellvie AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 12, 2021Media
Thurgauer Biotech-Start-up Cellvie kämpft um einen Förderpreis
tagblatt.ch

Knowledge

No knowledge articles yet

Once cellvie AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

cellvie AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank cellvie AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of cellvie AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Technoparkstrasse 1
8005 Zurich

At a glance

Legal form
Corporation
UID
CHE-331.507.963
Founded
2020 · 6 years
Last commercial register change
July 12, 2022
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    PA
    Pallon AG
    Zurich
    HA
    hemotune AG
    Schlieren
    NB
    NoutriCode by Marciniak
    Erlenbach Zh
    CR
    Charles River Laboratories Switzerland AG
    Hettlingen
    LM
    LogObject Media AG
    Glattpark (Opfikon)
    RA
    Redbiotec AG
    Schlieren
    CA
    Clinipace AG
    Volketswil
    FS
    Fortrea Switzerland AG
    Zurich